This may hint at a link between CIMP CRC tumors, which are typically associated with BRAF and KRAS mutations but not IDH1 or TET mutations, and CIMP gliomas, which are associated with IDH1 mutations [50] but not BRAF or KRAS mutations. This evidence concerns the gene BRAF and colorectal carcinoma.